Greenwich lifesciences inc
WebApr 13, 2024 · Greenwich LifeSciences, Inc. (NASDAQ:GLSI – Get Rating) VP Jaye Thompson purchased 1,000 shares of the firm’s stock in a transaction dated Tuesday, April 11th.The shares were bought at an average price of $11.87 per share, for a total transaction of $11,870.00. Following the completion of the transaction, the vice president now owns … WebApr 14, 2024 · Greenwich LifeSciences, Inc. has a 12-month low of $6.82 and a 12-month high of $21.50. The firm’s 50-day moving average price is $14.92 and its two-hundred day moving average price is $13.48.
Greenwich lifesciences inc
Did you know?
WebApr 10, 2024 · Currently, the analyst consensus on Greenwich LifeSciences is a Moderate Buy with an average price target of $38.00. See Insiders’ Hot Stocks on TipRanks >> … WebGreenwich LifeSciences, Inc. Daily – Vickers Top Insider Picks for 04/07/2024 The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 …
WebGreenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. … WebApr 13, 2024 · Greenwich LifeSciences, Inc. (NASDAQ:GLSI – Get Rating) VP Jaye Thompson purchased 1,000 shares of the firm’s stock in a transaction dated Tuesday, …
WebSep 29, 2024 · STAFFORD, Texas-- ( BUSINESS WIRE )--Greenwich LifeSciences, Inc. (the “Company”), a clinical-stage biopharmaceutical company focused on the … WebDec 1, 2024 · Greenwich LifeSciences Provides Year End Update Dec 1, 2024 6:00am EST Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2024 Featured Events View All Events There are no events to show at this time. Sign up here to receive notices about upcoming events.
WebApr 10, 2024 · Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following … twc in mesquite texasWebApr 14, 2024 · Greenwich LifeSciences has a 52-week low of $6.82 and a 52-week high of $21.50. The stock’s fifty day simple moving average is $14.92 and its 200-day simple … twc intelligent home customer serviceWebLegal Name Greenwich LifeSciences, Inc. Stock Symbol NASDAQ:GLSI ; Company Type For Profit; Contact Email [email protected]; Phone Number (832) 819-3232; twc intellistarWebGreenwich LifeSciences (Nasdaq: GLSI) is a public clinical-stage biopharmaceutical company focused on the development of an immunotherapy to prevent breast cancer … Greenwich LifeSciences, Inc. (Nasdaq: GLSI) is a public biopharmaceutical … GP2 immunotherapy trains a patient’s T cells to recognize and destroy … The current, ongoing trial is a Phase III clinical trial registered with the name, … Company Profile. Business Description: Greenwich LifeSciences (the … about. management team; board of directors; technology. our gp2 cancer … Dr. Thompson has over 30 years of experience in pharmaceutical and … GP2 is a nine amino acid transmembrane peptide of the HER2/neu protein. … Understand cancer and immunotherapy, cancer’s escape from … Greenwich LifeSciences Provides Year End Update. Dec 1, 2024 6:00am EST. … Company Info - Greenwich LifeSciences, Inc. (GLSI) GP2 twc internet free installationWebabout. management team; board of directors; technology. our gp2 cancer immunotherapy product; cancer and immunotherapy background; clinical trials. completed phase iib clinical trial twc in financeWebApr 11, 2024 · NASDAQ:GLSI opened at $12.65 on Monday. Greenwich LifeSciences has a 52 week low of $6.82 and a 52 week high of $21.50. The stock’s fifty day moving average is $15.24 and its two-hundred day ... twc in planoWebSnehal S. Patel Chief Executive Officer. Over 30 years of experience in executive management, corporate development, operations, and investment banking in the … tw cipher\u0027s